APO Research
Talk to an analyst

APO RESEARCH · REPORT

Sufentanil (API)

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Sufentanil (API) Industry Growth and Trends Forecast to 2032

20 December 202591 pages

Choose your research edition.

Industry ResearchSufentanil (API) Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Sufentanil (API) Industry Growth and Trends Forecast to 203291 pages · $3,450 USDMarket StructureGlobal Sufentanil (API) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032187 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Sufentanil (API) Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Sufentanil (API) Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Sufentanil (API) market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Sufentanil (API) is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Sufentanil (API) is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Sufentanil (API) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Sufentanil (API) include Janssen Pharmaceuticals, Kern Pharma, Hameln Rds, Cristalia and Cambrex, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Sufentanil (API) market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Sufentanil (API) market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Sufentanil (API) market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Sufentanil (API).

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Sufentanil (API) market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Sufentanil (API) Market by Company

Janssen Pharmaceuticals

Kern Pharma

Hameln Rds

Cristalia

Cambrex

Sufentanil (API) Segment by Type

Purity 98%

Purity 99%

Sufentanil (API) Segment by Application

Injection

Capsule

Sufentanil (API) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sufentanil (API) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Sufentanil (API) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sufentanil (API).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Sufentanil (API) manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Sufentanil (API) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Purity 98% Table 2. Major Company of Purity 99% Table 3. Global Sufentanil (API) Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Sufentanil (API) Sales by Type (2021-2026) & (k units) Table 5. Global Sufentanil (API) Sales Market Share in Volume by Type (2021-2026) Table 6. Global Sufentanil (API) Sales by Type (2021-2026) & (US$ Million) Table 7. Global Sufentanil (API) Sales Market Share in Value by Type (2021-2026) Table 8. Global Sufentanil (API) Price by Type (2021-2026) & (US$/unit) Table 9. Global Sufentanil (API) Sales by Type (2027-2032) & (k units) Table 10. Global Sufentanil (API) Sales Market Share in Volume by Type (2027-2032) Table 11. Global Sufentanil (API) Sales by Type (2027-2032) & (US$ Million) Table 12. Global Sufentanil (API) Sales Market Share in Value by Type (2027-2032) Table 13. Global Sufentanil (API) Price by Type (2027-2032) & (US$/unit) Table 14. North America Sufentanil (API) Sales by Type (2021-2026) & (k units) Table 15. North America Sufentanil (API) Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Sufentanil (API) Sales by Type (2021-2026) & (k units) Table 17. Europe Sufentanil (API) Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Sufentanil (API) Sales by Type (2021-2026) & (k units) Table 19. Asia-Pacific Sufentanil (API) Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Sufentanil (API) Sales by Type (2021-2026) & (k units) Table 21. Latin America Sufentanil (API) Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Sufentanil (API) Sales by Type (2021-2026) & (k units) Table 23. Middle East and Africa Sufentanil (API) Sales by Type (2021-2026) & (US$ Million) Table 24. Sufentanil (API) Industry Trends Table 25. Sufentanil (API) Industry Drivers Table 26. Sufentanil (API) Industry Opportunities and Challenges Table 27. Sufentanil (API) Industry Restraints Table 28. Global Sufentanil (API) Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Sufentanil (API) Revenue Market Share by Company (2021-2026) Table 30. Global Sufentanil (API) Sales by Company (2021-2026) & (k units) Table 31. Global Sufentanil (API) Sales Share by Company (2021-2026) Table 32. Global Sufentanil (API) Market Price by Company (2021-2026) & (US$/unit) Table 33. Global Sufentanil (API) Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Sufentanil (API) Major Company Production Sites and Headquarters Table 35. Global Sufentanil (API) Company, Product Type & Application Table 36. Global Sufentanil (API) Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Sufentanil (API) by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Sufentanil (API) Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Sufentanil (API) Sales by Region (2021-2026) & (k units) Table 41. Global Sufentanil (API) Sales Market Share in Volume by Region (2021-2026) Table 42. Global Sufentanil (API) Sales by Region (2021-2026) & (US$ Million) Table 43. Global Sufentanil (API) Sales Market Share in Value by Region (2021-2026) Table 44. Global Sufentanil (API) Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 45. Global Sufentanil (API) Sales by Region (2027-2032) & (k units) Table 46. Global Sufentanil (API) Sales Market Share in Volume by Region (2027-2032) Table 47. Global Sufentanil (API) Sales by Region (2027-2032) & (US$ Million) Table 48. Global Sufentanil (API) Sales Market Share in Value by Region (2027-2032) Table 49. Global Sufentanil (API) Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 50. Global Sufentanil (API) Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Sufentanil (API) Sales by Application (2021-2026) & (k units) Table 52. Global Sufentanil (API) Sales Market Share in Volume by Application (2021-2026) Table 53. Global Sufentanil (API) Sales by Application (2021-2026) & (US$ Million) Table 54. Global Sufentanil (API) Sales Market Share in Value by Application (2021-2026) Table 55. Global Sufentanil (API) Price by Application (2021-2026) & (US$/unit) Table 56. Global Sufentanil (API) Sales by Application (2027-2032) & (k units) Table 57. Global Sufentanil (API) Sales Market Share in Volume by Application (2027-2032) Table 58. Global Sufentanil (API) Sales by Application (2027-2032) & (US$ Million) Table 59. Global Sufentanil (API) Sales Market Share in Value by Application (2027-2032) Table 60. Global Sufentanil (API) Price by Application (2027-2032) & (US$/unit) Table 61. North America Sufentanil (API) Sales by Application (2021-2026) & (k units) Table 62. North America Sufentanil (API) Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Sufentanil (API) Sales by Application (2021-2026) & (k units) Table 64. Europe Sufentanil (API) Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Sufentanil (API) Sales by Application (2021-2026) & (k units) Table 66. Asia-Pacific Sufentanil (API) Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Sufentanil (API) Sales by Application (2021-2026) & (k units) Table 68. Latin America Sufentanil (API) Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Sufentanil (API) Sales by Application (2021-2026) & (k units) Table 70. Middle East and Africa Sufentanil (API) Sales by Application (2021-2026) & (US$ Million) Table 71. Janssen Pharmaceuticals Company Information Table 72. Janssen Pharmaceuticals Business Overview Table 73. Janssen Pharmaceuticals Sufentanil (API) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. Janssen Pharmaceuticals Sufentanil (API) Product Portfolio Table 75. Janssen Pharmaceuticals Recent Development Table 76. Kern Pharma Company Information Table 77. Kern Pharma Business Overview Table 78. Kern Pharma Sufentanil (API) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. Kern Pharma Sufentanil (API) Product Portfolio Table 80. Kern Pharma Recent Development Table 81. Hameln Rds Company Information Table 82. Hameln Rds Business Overview Table 83. Hameln Rds Sufentanil (API) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 84. Hameln Rds Sufentanil (API) Product Portfolio Table 85. Hameln Rds Recent Development Table 86. Cristalia Company Information Table 87. Cristalia Business Overview Table 88. Cristalia Sufentanil (API) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 89. Cristalia Sufentanil (API) Product Portfolio Table 90. Cristalia Recent Development Table 91. Cambrex Company Information Table 92. Cambrex Business Overview Table 93. Cambrex Sufentanil (API) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 94. Cambrex Sufentanil (API) Product Portfolio Table 95. Cambrex Recent Development Table 96. North America Sufentanil (API) Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 97. North America Sufentanil (API) Sales by Country (2021-2026) & (k units) Table 98. North America Sufentanil (API) Sales Market Share by Country (2021-2026) Table 99. North America Sufentanil (API) Sales Forecast by Country (2027-2032) & (k units) Table 100. North America Sufentanil (API) Sales Market Share Forecast by Country (2027-2032) Table 101. North America Sufentanil (API) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 102. North America Sufentanil (API) Market Size by Country (2021-2026) & (US$ Million) Table 103. North America Sufentanil (API) Market Share by Country (2021-2026) Table 104. North America Sufentanil (API) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 105. North America Sufentanil (API) Market Share Forecast by Country (2027-2032) Table 106. Europe Sufentanil (API) Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 107. Europe Sufentanil (API) Sales by Country (2021-2026) & (k units) Table 108. Europe Sufentanil (API) Sales Market Share by Country (2021-2026) Table 109. Europe Sufentanil (API) Sales Forecast by Country (2027-2032) & (k units) Table 110. Europe Sufentanil (API) Sales Market Share Forecast by Country (2027-2032) Table 111. Europe Sufentanil (API) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 112. Europe Sufentanil (API) Market Size by Country (2021-2026) & (US$ Million) Table 113. Europe Sufentanil (API) Market Share by Country (2021-2026) Table 114. Europe Sufentanil (API) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 115. Europe Sufentanil (API) Market Share Forecast by Country (2027-2032) Table 116. Asia-Pacific Sufentanil (API) Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 117. Asia-Pacific Sufentanil (API) Sales by Country (2021-2026) & (k units) Table 118. Asia-Pacific Sufentanil (API) Sales Market Share by Country (2021-2026) Table 119. Asia-Pacific Sufentanil (API) Sales Forecast by Country (2027-2032) & (k units) Table 120. Asia-Pacific Sufentanil (API) Sales Market Share Forecast by Country (2027-2032) Table 121. Asia-Pacific Sufentanil (API) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 122. Asia-Pacific Sufentanil (API) Market Size by Country (2021-2026) & (US$ Million) Table 123. Asia-Pacific Sufentanil (API) Market Share by Country (2021-2026) Table 124. Asia-Pacific Sufentanil (API) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 125. Asia-Pacific Sufentanil (API) Market Share Forecast by Country (2027-2032) Table 126. Latin America Sufentanil (API) Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 127. Latin America Sufentanil (API) Sales by Country (2021-2026) & (k units) Table 128. Latin America Sufentanil (API) Sales Market Share by Country (2021-2026) Table 129. Latin America Sufentanil (API) Sales Forecast by Country (2027-2032) & (k units) Table 130. Latin America Sufentanil (API) Sales Market Share Forecast by Country (2027-2032) Table 131. Latin America Sufentanil (API) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. Latin America Sufentanil (API) Market Size by Country (2021-2026) & (US$ Million) Table 133. Latin America Sufentanil (API) Market Share by Country (2021-2026) Table 134. Latin America Sufentanil (API) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. Latin America Sufentanil (API) Market Share Forecast by Country (2027-2032) Table 136. Middle East and Africa Sufentanil (API) Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 137. Middle East and Africa Sufentanil (API) Sales by Country (2021-2026) & (k units) Table 138. Middle East and Africa Sufentanil (API) Sales Market Share by Country (2021-2026) Table 139. Middle East and Africa Sufentanil (API) Sales Forecast by Country (2027-2032) & (k units) Table 140. Middle East and Africa Sufentanil (API) Sales Market Share Forecast by Country (2027-2032) Table 141. Middle East and Africa Sufentanil (API) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. Middle East and Africa Sufentanil (API) Market Size by Country (2021-2026) & (US$ Million) Table 143. Middle East and Africa Sufentanil (API) Market Share by Country (2021-2026) Table 144. Middle East and Africa Sufentanil (API) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. Middle East and Africa Sufentanil (API) Market Share Forecast by Country (2027-2032) Table 146. Key Raw Materials Table 147. Raw Materials Key Suppliers Table 148. Sufentanil (API) Distributors List Table 149. Sufentanil (API) Customers List Table 150. Research Programs/Design for This Report Table 151. Authors List of This Report Table 152. Secondary Sources Table 153. Primary Sources List of Figures Figure 1. Sufentanil (API) Image Figure 2. Global Sufentanil (API) Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Sufentanil (API) Market Size (2021-2032) & (US$ Million) Figure 4. Global Sufentanil (API) Sales (2021-2032) & (k units) Figure 5. Purity 98% Image Figure 6. Global Purity 98% Sales YoY Growth (2021-2032) & (k units) Figure 7. Purity 99% Image Figure 8. Global Purity 99% Sales YoY Growth (2021-2032) & (k units) Figure 9. Global Sufentanil (API) Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Sufentanil (API) Market Share by Type 2025 VS 2032 Figure 11. North America Sufentanil (API) Sales Market Share in Volume by Type in 2025 Figure 12. North America Sufentanil (API) Sales Market Share in Value by Type in 2025 Figure 13. Europe Sufentanil (API) Sales Market Share in Volume by Type in 2025 Figure 14. Europe Sufentanil (API) Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Sufentanil (API) Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Sufentanil (API) Sales Market Share in Value by Type in 2025 Figure 17. Latin America Sufentanil (API) Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Sufentanil (API) Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Sufentanil (API) Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Sufentanil (API) Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Sufentanil (API) Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Injection Image Figure 24. Global Injection Sales YoY Growth (2021-2032) & (k units) Figure 25. Capsule Image Figure 26. Global Capsule Sales YoY Growth (2021-2032) & (k units) Figure 27. Global Sufentanil (API) Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Sufentanil (API) Market Share by Application 2025 VS 2032 Figure 29. North America Sufentanil (API) Sales Market Share in Volume by Application in 2025 Figure 30. North America Sufentanil (API) Sales Market Share in Value by Application in 2025 Figure 31. Europe Sufentanil (API) Sales Market Share in Volume by Application in 2025 Figure 32. Europe Sufentanil (API) Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Sufentanil (API) Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Sufentanil (API) Sales Market Share in Value by Application in 2025 Figure 35. Latin America Sufentanil (API) Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Sufentanil (API) Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Sufentanil (API) Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Sufentanil (API) Sales Market Share in Value by Application in 2025 Figure 39. North America Sufentanil (API) Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 40. North America Sufentanil (API) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Sufentanil (API) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Sufentanil (API) Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Sufentanil (API) Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 44. Europe Sufentanil (API) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Sufentanil (API) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Sufentanil (API) Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Sufentanil (API) Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 48. Asia-Pacific Sufentanil (API) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Sufentanil (API) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Sufentanil (API) Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Sufentanil (API) Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 52. Latin America Sufentanil (API) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Sufentanil (API) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Sufentanil (API) Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Sufentanil (API) Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 56. Middle East and Africa Sufentanil (API) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Sufentanil (API) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Sufentanil (API) Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Sufentanil (API) Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Sufentanil (API) Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Purity 98%
  • Purity 99%
Applications
  • Injection
  • Capsule
Companies covered
  • Janssen Pharmaceuticals
  • Kern Pharma
  • Hameln Rds
  • Cristalia
  • Cambrex

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Sufentanil (API) Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Sufentanil (API) Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Sufentanil (API) Market by Type
  6. 1.3.1 Purity 98%
  7. 1.3.2 Purity 99%
  8. 1.4 Global Sufentanil (API) Market Size by Type
  9. 1.4.1 Global Sufentanil (API) Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Sufentanil (API) Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Sufentanil (API) Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Sufentanil (API) Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Sufentanil (API) Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Sufentanil (API) Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Sufentanil (API) Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Sufentanil (API) Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Sufentanil (API) Industry Trends
  2. 2.2 Sufentanil (API) Industry Drivers
  3. 2.3 Sufentanil (API) Industry Opportunities and Challenges
  4. 2.4 Sufentanil (API) Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Sufentanil (API) Revenue (2021-2026)
  2. 3.2 Global Top Players by Sufentanil (API) Sales (2021-2026)
  3. 3.3 Global Top Players by Sufentanil (API) Price (2021-2026)
  4. 3.4 Global Sufentanil (API) Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Sufentanil (API) Major Company Production Sites & Headquarters
  6. 3.6 Global Sufentanil (API) Company, Product Type & Application
  7. 3.7 Global Sufentanil (API) Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Sufentanil (API) Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Sufentanil (API) Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Sufentanil (API) Tier 1, Tier 2, and Tier 3
4 Sufentanil (API) Regional Status and Outlook
  1. 4.1 Global Sufentanil (API) Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Sufentanil (API) Historic Market Size by Region
  3. 4.2.1 Global Sufentanil (API) Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Sufentanil (API) Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Sufentanil (API) Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Sufentanil (API) Forecasted Market Size by Region
  7. 4.3.1 Global Sufentanil (API) Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Sufentanil (API) Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Sufentanil (API) Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Sufentanil (API) by Application
  1. 5.1 Sufentanil (API) Market by Application
  2. 5.1.1 Injection
  3. 5.1.2 Capsule
  4. 5.2 Global Sufentanil (API) Market Size by Application
  5. 5.2.1 Global Sufentanil (API) Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Sufentanil (API) Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Sufentanil (API) Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Sufentanil (API) Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Sufentanil (API) Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Sufentanil (API) Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Sufentanil (API) Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Sufentanil (API) Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Janssen Pharmaceuticals
  2. 6.1.1 Janssen Pharmaceuticals Company Information
  3. 6.1.2 Janssen Pharmaceuticals Business Overview
  4. 6.1.3 Janssen Pharmaceuticals Sufentanil (API) Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Janssen Pharmaceuticals Sufentanil (API) Product Portfolio
  6. 6.1.5 Janssen Pharmaceuticals Recent Developments
  7. 6.2 Kern Pharma
  8. 6.2.1 Kern Pharma Company Information
  9. 6.2.2 Kern Pharma Business Overview
  10. 6.2.3 Kern Pharma Sufentanil (API) Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Kern Pharma Sufentanil (API) Product Portfolio
  12. 6.2.5 Kern Pharma Recent Developments
  13. 6.3 Hameln Rds
  14. 6.3.1 Hameln Rds Company Information
  15. 6.3.2 Hameln Rds Business Overview
  16. 6.3.3 Hameln Rds Sufentanil (API) Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Hameln Rds Sufentanil (API) Product Portfolio
  18. 6.3.5 Hameln Rds Recent Developments
  19. 6.4 Cristalia
  20. 6.4.1 Cristalia Company Information
  21. 6.4.2 Cristalia Business Overview
  22. 6.4.3 Cristalia Sufentanil (API) Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Cristalia Sufentanil (API) Product Portfolio
  24. 6.4.5 Cristalia Recent Developments
  25. 6.5 Cambrex
  26. 6.5.1 Cambrex Company Information
  27. 6.5.2 Cambrex Business Overview
  28. 6.5.3 Cambrex Sufentanil (API) Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Cambrex Sufentanil (API) Product Portfolio
  30. 6.5.5 Cambrex Recent Developments
7 North America by Country
  1. 7.1 North America Sufentanil (API) Sales by Country
  2. 7.1.1 North America Sufentanil (API) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Sufentanil (API) Sales by Country (2021-2026)
  4. 7.1.3 North America Sufentanil (API) Sales Forecast by Country (2027-2032)
  5. 7.2 North America Sufentanil (API) Market Size by Country
  6. 7.2.1 North America Sufentanil (API) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Sufentanil (API) Market Size by Country (2021-2026)
  8. 7.2.3 North America Sufentanil (API) Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Sufentanil (API) Sales by Country
  2. 8.1.1 Europe Sufentanil (API) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Sufentanil (API) Sales by Country (2021-2026)
  4. 8.1.3 Europe Sufentanil (API) Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Sufentanil (API) Market Size by Country
  6. 8.2.1 Europe Sufentanil (API) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Sufentanil (API) Market Size by Country (2021-2026)
  8. 8.2.3 Europe Sufentanil (API) Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Sufentanil (API) Sales by Country
  2. 9.1.1 Asia-Pacific Sufentanil (API) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Sufentanil (API) Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Sufentanil (API) Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Sufentanil (API) Market Size by Country
  6. 9.2.1 Asia-Pacific Sufentanil (API) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Sufentanil (API) Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Sufentanil (API) Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Sufentanil (API) Sales by Country
  2. 10.1.1 South America Sufentanil (API) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Sufentanil (API) Sales by Country (2021-2026)
  4. 10.1.3 South America Sufentanil (API) Sales Forecast by Country (2027-2032)
  5. 10.2 South America Sufentanil (API) Market Size by Country
  6. 10.2.1 South America Sufentanil (API) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Sufentanil (API) Market Size by Country (2021-2026)
  8. 10.2.3 South America Sufentanil (API) Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Sufentanil (API) Sales by Country
  2. 11.1.1 Middle East and Africa Sufentanil (API) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Sufentanil (API) Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Sufentanil (API) Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Sufentanil (API) Market Size by Country
  6. 11.2.1 Middle East and Africa Sufentanil (API) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Sufentanil (API) Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Sufentanil (API) Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Sufentanil (API) Value Chain Analysis
  2. 12.1.1 Sufentanil (API) Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Sufentanil (API) Production Mode & Process
  7. 12.2 Sufentanil (API) Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Sufentanil (API) Distributors
  10. 12.2.3 Sufentanil (API) Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst